Novo Companies to Invest Billions in Danish Research (in Danish) (Sun, 29 Aug 2010)

Epitherapeutics extends seed financing round, OSI Pharmaceuticals Inc. joins Syndicate (Fri, 27 Aug 2010)

Sweden is World Top 5 in Developing Biotech (in Swedish) (Thu, 26 Aug 2010)

NeuroSearch Appoints New CEO (Tue, 24 Aug 2010)

Less Clinical Trials Conducted in Denmark (in Swedish) (Fri, 20 Aug 2010)

Pharmacosmos Establishes Pharmacosmos CRO A/S (Thu, 19 Aug 2010)

The MVA News Section Is Closed in July-August due to Holiday (Fri, 9 Jul 2010)

SEED Capital Has Invested in 5 Life Science Companies in Q1-Q2 of 2010 (Thu, 8 Jul 2010)

Medicoindustrien Elects New Chairman of the Board (in Danish) (Wed, 7 Jul 2010)

Nycomed’s Anti-Inflammatory Therapy Daxas® Receives Marketing Authorisation in the EU (Tue, 6 Jul 2010)

LifeCycle Pharma Announces Positive Results of Phase 2 Clinical Trial in Kidney Patients (Mon, 5 Jul 2010)

Comment from MVA in Børsen: Tailwind for Medicon Valley (in Danish) (Wed, 30 Jun 2010)

ALK's Acquisition of the Largest Allergy Vaccine Company in The Netherlands Approved (Tue, 29 Jun 2010)

Business.dk: Danish Biotech is 15 Billion Short (in Danish) (Mon, 28 Jun 2010)

New Data Demonstrate the Benefits of Victoza® (liraglutide) (Sat, 26 Jun 2010)

Beyond Borders 2010: Danish Biotech Is Loosing Ground (Thu, 24 Jun 2010)

Increasingly More Projects Are Tapped in Phase II (in Swedish) (Thu, 24 Jun 2010)

Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance (Wed, 23 Jun 2010)

AstraZeneca and Targacept Initiate Phase 3 Clinical Development of TC-5214 (Wed, 23 Jun 2010)

Novo Nordisk Re-Initiates Phase 3 Development of Liraglutide for Obesity (Tue, 22 Jun 2010)

TV2/Lorry and Sydnytt: Medicon Valley - 10 Years After the Oresund Bridge (Tue, 22 Jun 2010)

Exiqon Licenses Locked Nucleic Acids for Infectious Disease Diagnostics to BD (Mon, 21 Jun 2010)

Three Billion to New Innovative Medicines Initiative Project (in Swedish) (Fri, 18 Jun 2010)

Danish national radio: One-hour debate about attracting capital to Medicon Valley (in Danish) (Fri, 18 Jun 2010)

Daniel Spasic of TFS Is This Year's Founder in Southern Sweden (in Swedish) (Wed, 16 Jun 2010)

Genmab Announces Change in Management (Tue, 15 Jun 2010)

Genzyme’s Alemtuzumab for Treatment of Multiple Sclerosis Granted Fast Track Status by FDA (Mon, 14 Jun 2010)

Chemel AB Appoints New CEO (in Swedish) (Thu, 10 Jun 2010)

Virogates: Single Blood Test Can Predict Severe Diseases and Mortality (Thu, 10 Jun 2010)

Article in Nature: Spotlight on the Diverse Opportunities of Danish Life Science (Thu, 10 Jun 2010)

Zealand Pharma Extends The Lixisenatide Global Licensing Agreement with sanofi-aventis (Thu, 10 Jun 2010)

Genzyme and Carl Icahn Reach Agreement (Wed, 9 Jun 2010)

New Bio-chip Technology Will Prompt Cheaper and Faster Development of Medicine (Wed, 9 Jun 2010)

Action Pharma Obtains Encouraging Preliminary Results in a Phase II Clinical Trial with AP214 (Wed, 9 Jun 2010)

Active Biotech's TASQ Prostate Cancer Project Presented at ASCO (Mon, 7 Jun 2010)

Osaka University and Medicon Valley Alliance Engage in Strategic Partnership (Mon, 7 Jun 2010)

AstraZeneca Receives FDA Complete Response Letter for AXANUM New Drug Application (Sat, 5 Jun 2010)

Ground-breaking Results Give Virogates New Prospects within Prognosis (Fri, 4 Jun 2010)

Novo Nordisk: Victoza® To Be Launched in Japan in June (2 June 2010) (Wed, 2 Jun 2010)

Region Skåne Is Investing 75 million in Strategic Research (in Swedish) (Wed, 2 Jun 2010)